Many breast cancer survivors not getting recommended mammograms

April 24, 2006

A new study finds use of annual mammography among breast cancer survivors, who are at increased risk of a recurrence or a new malignancy in the other breast, dropped off after a few years. During the five year study period, only one in three women in this high-risk population had received regular annual mammograms. Published in the June 1, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study reveals the most significant factors predicting who got screened included being seen by a gynecologist or primary care physician and having been treated with breast conserving surgery.

There are more than 2.3 million women in the United States who have been treated for breast cancer. Women with a history of breast cancer face a three-fold increased risk of a malignancy in the other breast. Recommendations for follow-up of these women include annual mammography for early identification of subsequent cancers. In the general population, mammography has been demonstrated to be effective at reducing mortality. In breast cancer survivors, mammography has been shown to identify tumors at early stages, when treatment is more successful.

Existing studies show that mammography is underutilized by the general population and by Medicare beneficiaries who survived breast cancer. However, little is known about how often survivors with managed care health insurance are screened and how non-financial factors impact its use.

Chyke A. Doubeni, M.D., M.P.H. of the University of Massachusetts Medical School and colleagues reviewed mammography use in 797 women over the age of 55 who had been treated for breast cancer. Their objective was to identify patterns of mammography utilization in women when health insurance coverage is not a factor.

The researchers found that in the first year after treatment, 80 percent of women had received a screening mammogram. At the fifth year of follow-up, only 63 percent had received a mammogram that year, and only one in three women (33 percent) had received a mammogram each year over the five years.

Women who were being cared for by their gynecologist or primary care physician were the most likely to have mammograms in the fifth year. While the impact of physician specialty in mammography screening has been demonstrated in the general population, this is the first report of this association in breast cancer survivors. In addition, older women, particularly those with other medical conditions, and those with late-stage tumors were significantly less likely to have a mammogram.

The study indicates regular mammography for breast cancer survivors declines steadily within five years of treatment. "Efforts are needed to increase awareness among healthcare providers and breast cancer survivors on the value of follow-up mammography," say the authors.
-end-
Article: "Patterns and Predictors of Mammography Utilization Among Breast Cancer Survivors," Chyke A. Doubeni, Terry S. Field, Marianne Ulcickas Yood, Sharon J. Rolnick, Charles P. Quessenberry, Hassan Fouayzi, Jerry H. Gurwitz, Feifei Wei, CANCER; Published Online: April 24, 2006 (DOI: 10.1002/cncr.21893); Print Issue Date: June 1, 2006.

Wiley

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.